Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificial intelligence are now commonplace, and this rapid evolution has left us with a significant knowledge gap within the medical community. In this paper, we attempt to bridge that gap and prepare the physician in oncology for multiomics, a group of technologies that have gone from looming on the horizon to become a clinical reality. The era of multiomics is here, and we must prepare ourselves for this exciting new age of cancer medicine.

Original publication

DOI

10.1093/oncolo/oyab048

Type

Journal article

Journal

Oncologist

Publication Date

05/04/2022

Volume

27

Pages

272 - 284

Keywords

artificial intelligence, cancer, digital pathology, genomics, machine learning, multiomics, proteomics, transcriptomics, Artificial Intelligence, Genomics, Humans, Medical Oncology, Neoplasms, Proteomics